TABLE I. Biosensors Strategies Reported for SARS-CoV-2 N Protein Detection.
Transducer Technique | Sample matrix | Limit of detection | Ref |
---|---|---|---|
LFA* | Buffer | 0.65 ng/mL (Genemedi) 3.03 ng/mL (GenScript) |
[8] |
Electrochemical# | Whole serum 5× diluted serum | 0.23 ng/mL 0.1 ng/mL | [11] |
Electrochemical* | Buffer Saliva |
4 ng/mL 8 ng/mL |
[14] |
Field effect Transistor* | Buffer | 0.016 fg/mL | [15] |
LFA* | Buffer | 2 ng/mL | [16] |
LFA# | Buffer | 2.2 ng/mL | [17] |
Electrochemical# | Buffer | ~0.7 pg/mL | [28] |
Electrochemical# | Buffer | 8.33 pg/mL | [27] |
Microfiber* | Buffer Fetal bovine serum | ~3 fg/mL 50 ng/mL | [29] |
P-FAB* | PBS Buffer | 2.48 ng/mL | Present study |
Recombinant SARS-CoV-2 N-protein,
SARS-CoV-2 N-protein